# Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD

Study · id `cardio:ct-nct05359263` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05359263](<https://clinicaltrials.gov/study/NCT05359263>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05359263

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 222 participants.

## Technical summary

Registry record NCT05359263. Randomized; triple masking; primary purpose treatment. Start 2022-06-08 (actual); primary completion 2025-02-18 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 222 participants (planned count; ClinicalTrials.gov record NCT05359263, source copy `cardio:ctgov-nct05359263-2025-02-10`, retrieved 2026-10-26)
- Started: 2022-06-08 (actual) (ClinicalTrials.gov record NCT05359263, source copy `cardio:ctgov-nct05359263-2025-02-10`, retrieved 2026-10-26)
- Primary completion: 2025-02-18 (anticipated) (ClinicalTrials.gov record NCT05359263, source copy `cardio:ctgov-nct05359263-2025-02-10`, retrieved 2026-10-26)
- Completion: 2025-02-18 (anticipated) (ClinicalTrials.gov record NCT05359263, source copy `cardio:ctgov-nct05359263-2025-02-10`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT05359263, source copy `cardio:ctgov-nct05359263-2025-02-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05359263-2025-02-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD
- Acronym: DECODE-CKD
- Condition: Chronic Kidney Diseases
- Intervention (Drug): Dapagliflozin 10 mg
- Intervention (Drug): Placebo
- Lead sponsor: Tor Biering-Sørensen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Dapagliflozin (`cardio:dapagliflozin`)
- Registry intervention is a member of this class by a sourced record link: SGLT2 inhibitors (drug class) (`cardio:sglt2-inhibitors`)
- Registry lists this organization as the lead sponsor: Tor Biering-Sørensen (`cardio:org-tor-biering-srensen-bf541f`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease (`cardio:pubmed-41147829`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d1e7e20eedae5596fd322117c37d5389adf8f5469051f74a873b115000440917
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
